GENETIC CLONAL DIVERSITY AS BIOMARKER FOR AGGRESSIVE GLEASON 7 PROSTATE CANCER

$393,750FY2012Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →